It has been speculated that men with the CYP3A4*1B genotype may have altered testosterone metabolism, promoting androgen-mediated prostate carcinogenesis and the occurrence of PRCa (Rebbeck et al, 1998). The gene discussed is CYP3A4; the disease is pure red-cell aplasia.